Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis

NCT04462055 · clinicaltrials.gov ↗
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class

Stopped Not feasible to include patients (due to e.g. COVID-19, patients with severe reactions not willing to undergo 2 food challenges, lower number of eligible patients than expected)

Conditions

Sponsor

UMC Utrecht